We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Pre-market futures are off early morning lows, but still fairly deep in the red at this hour. Following a prime-time speech from President Trump yesterday, where investors sought signs that the military conflict in Iran would soon come to an end, the lack of details toward that end left us wanting. The Dow is -634 points at this hour, -1.35%, the S&P 500 is -98 points, -1.48%, the Nasdaq -459 points, -1.90%, and the small-cap Russell 2000 -51 points, -2.05%.
Oil prices shot up +12% earlier this morning, but have cooled somewhat of late. The WTI went up to $112 per barrel (/bbl) this morning, while the Brent rose +8% to $109/bbl (contract expiration dates explain how WTI is at a higher price point, which is not normal). The prolonged closing of the Strait of Hormuz clamps 20 million barrels of oil per day, and without a solution in view, the initial estimate of “four to six weeks” of a military operation in Iran threatens to go on far longer. (We’re already in Week 5.)
Jobless Claims Reflect a Healthy Labor Market
Meanwhile, all appears to be hunky dory on Weekly Jobless Claims. Last week’s Initial Jobless Claims reached 202K, historically very low and the slimmest headline since the first half of January, when seasonal employment elements were still in play. New jobless claims are currently down to nearly two-year lows.
Continuing Claims bumped up somewhat to 1.841 million two weeks ago (a week in arrears from new claims), but from a downwardly revised 1.816 million the previous week, which we haven’t seen since May of 2024. We continue to see a “low hire/low fire” labor environment, which tends to make these weekly labor numbers look much stronger than we’ve seen in other employment reports (see below).
Offices Closed Friday, but BLS Jobs Still Reports
NOTE: Zacks’ offices are closed tomorrow in observance of Good Friday, as are the domestic markets. Yet the new Employment Situation report from the U.S. Bureau of Labor Statistics (BLS) will still be released Friday morning. Investors will have all weekend to marinate in the results before trading on the news come Monday.
Expectations are for +59K jobs to have been created in March, up from the -92K reported a month ago, which was the deepest cut to domestic jobs since October 2025’s dire -140K. Our four-month average is currently the lowest we’ve seen since the Covid pandemic: -20K per month. The Unemployment Rate is expected to remain at a still-docile 4.4%.
Wage growth is predicted to tick down 10 basis points (bps) both month over month and year over year, to +0.3% and +3.7%, respectively. As we saw in Wednesday’s ADPADP private sector jobs report for March, those who changed jobs saw a slightly higher increase in pay, although these figures are still subdued overall.
Key also in these numbers will be revisions to previous months, which are often significant. Obviously, revisions can go either way, but of late they generally move lower. It’s tough to anticipate, however, even with ADP figures just reported, somewhat due to the placid jobless claims reports we keep getting every week.
We cover more than 1,000 of the most widely followed stocks in our Equity Research Reports. Each report features independent research from our analysts and provides in-depth analysis on a company, its fundamentals and its growth prospects. Quickly access reports for New Upgrades and New Downgrades.
You can also find a report on the ticker of your choice, or access all of the stock reports covered by Zacks analysts.
Strength across both the segments, 3D strategy and acquisitions should continue to drive Flowserve’s growth. The company’s shareholder-friendly policies spark optimism.
Stryker’s strong organic growth, robotics leadership, innovative product launches, and margin expansion strategies position it to outperform peers and capture long-term structural healthcare demand.
Caterpillar’s focus on innovation, investment in digital capabilities and demand stemming from infrastructure spending and energy-transition trends should help it maintain an upbeat performance.
Focus on the Permian region, sale proceeds from the chemical business will assist in further reduction of debts, strength in international operation and benefits from the acquisition will boost performance.
AI-driven semiconductor innovation, advanced packaging and market share gains in foundry logic to fuel growth. Strong balance sheet, expanding customer base and focus on cutting-edge semiconductor technologies are other positives.
Headwinds from geopolitical concerns and uncertainty in the healthcare industry continue to bother Avanos. Other issues like forex volatility, macroeconomic concerns and stiff competition persist.
Doximity’s strong position is tempered by risks—heavy reliance on top pharma clients, cyclical budgets, slowing engagement, and execution hurdles in scaling new verticals.
Brighthouse Financial's increasing expenses weighing on margin expansion, high debt level leading to higher leverage coupled with lower interest coverage keeps us on the sideline.
Risks related to the shortage of labor and lingering supply chain challenges raise concerns for the stock. The adverse impact of tariff imposition also poses a risk
American Eagle is well placed on cost-reduction efforts and brand progress. In the second half, the company expects to cycle tariffs and advertising investments.
Broadcom is a leading player in the semiconductor market based on its expanding product portfolio, multiple target markets, accretive acquisitions and strong cash flow.
Strength in the Energy Generation/Storage business, balance sheet strength, and focus on autonomous driving, robotics and artificial intelligence are set to drive Tesla.
AT&T is witnessing early momentum in its core market areas driven by strength in 5G and fiber, as it aims to better harness edge computing capabilities with core business focus.
Align Technology’s robust product line, balanced growth across all channels and consistent focus on international markets to drive growth bolster our confidence in the stock.
Amgen’s key medicines like Evenity and Repatha as well as newer medicines like Tavneos and Tezspire are driving sales, more than offsetting declining revenues from oncology biosimilars and legacy established products such as Enbrel